Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion: A Study Interrupted
- PMID: 26954405
- DOI: 10.1001/jama.2016.1461
Evaluation of the Cardiovascular Risk of Naltrexone-Bupropion: A Study Interrupted
Comment on
-
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.JAMA. 2016 Mar 8;315(10):990-1004. doi: 10.1001/jama.2016.1558. JAMA. 2016. PMID: 26954408 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
